NCT00115960View on ClinicalTrials.gov

Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

Not specified

Study Completion Date

July 31, 2008

Conditions
HIV Infections
Interventions
BIOLOGICAL

HIV-1 gag DNA

DNA vaccine containing the HIV gene gag

BIOLOGICAL

IL-15 DNA adjuvant

Cytokine injection

BIOLOGICAL

IL-12 DNA adjuvant

Cytokine injection

Trial Locations (7)

10003

NY Blood Ctr./Union Square CRS, New York

10032

HIV Prevention & Treatment CRS, New York

10456

NY Blood Ctr./Bronx CRS, The Bronx

02115

Brigham and Women's Hosp. CRS, Boston

14642-0001

Univ. of Rochester HVTN CRS, Rochester

Unknown

Miriam Hospital's HVTU, Providence

Sao Paulo HVTU - CRT DST/AIDS CRS, São Paulo

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH